Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Omega Protein (OME) Share Price

News articles about Omega Protein (NYSE:OME) have been trending somewhat positive on Wednesday, Accern reports. The research group rates the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Omega Protein earned a news impact score of 0.16 on Accern’s scale. Accern also gave headlines about the company an impact score of 45.6769566366042 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:

Omega Protein (NYSE OME) remained flat at $$21.95 during trading on Wednesday. The company’s stock had a trading volume of 964,000 shares, compared to its average volume of 292,156. Omega Protein has a one year low of $14.50 and a one year high of $26.99. The stock has a market capitalization of $493.41, a P/E ratio of 22.17 and a beta of 0.28.

Omega Protein (NYSE:OME) last posted its quarterly earnings results on Wednesday, November 8th. The company reported $0.09 EPS for the quarter, missing the Zacks’ consensus estimate of $0.31 by ($0.22). Omega Protein had a return on equity of 6.48% and a net margin of 5.45%. The company had revenue of $90.30 million during the quarter, compared to the consensus estimate of $96.65 million. During the same period in the previous year, the business earned $0.67 earnings per share. Omega Protein’s revenue was down 17.0% on a year-over-year basis.

Separately, ValuEngine raised Omega Protein from a “hold” rating to a “buy” rating in a report on Friday, December 1st.

COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Omega Protein (OME) Share Price” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://www.dispatchtribunal.com/2017/12/13/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-omega-protein-ome-share-price.html.

Omega Protein Company Profile

Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists of two subsidiaries: Omega Protein, Inc (Omega Protein) and Omega Shipyard, Inc (Omega Shipyard).

Insider Buying and Selling by Quarter for Omega Protein (NYSE:OME)

Receive News & Ratings for Omega Protein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Protein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply